In the latest trading session, 0.44 million Conduit Pharmaceuticals Inc (NASDAQ:CDT) shares changed hands as the company’s beta touched 2.18. With the company’s most recent
Conduit Pharmaceuticals Inc (NASDAQ:CDT) has a beta value of 2.19 and has seen 25.04 million shares traded in the last trading session. The CDT stock
During the last session, Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s traded shares were 72.49 million, with the beta value of the company hitting 2.29. At the end
In the last trading session, 16.26 million shares of the Conduit Pharmaceuticals Inc (NASDAQ:CDT) were traded, and its beta was 2.30. Most recently the company’s
In the last trading session, 13.2 million shares of the Conduit Pharmaceuticals Inc (NASDAQ:CDT) were traded, and its beta was 2.29. Most recently the company’s
Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s traded shares stood at 19.33 million during the last session, with the company’s beta value hitting 2.30. At the close of
Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s traded shares stood at 7.56 million during the latest session, with the company’s beta value hitting 2.30. At the last check
In the last trading session, 53.67 million Conduit Pharmaceuticals Inc (NASDAQ:CDT) shares changed hands as the company’s beta touched 2.09. With the company’s per share
In the last trading session, 1.16 billion Conduit Pharmaceuticals Inc (NASDAQ:CDT) shares changed hands as the company’s beta touched 2.28. With the company’s per share
In last trading session, Conduit Pharmaceuticals Inc (NASDAQ:CDT) saw 252.23 million shares changing hands with its beta currently measuring 2.26. Company’s recent per share price
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
